|
Volumn 61, Issue 4, 2004, Pages 351-358
|
Adenoviral gene therapy for pancreatic adenocarcinoma.
a a
a
Kentucky
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADENOCARCINOMA;
ADENOVIRUS;
CANCER STAGING;
CELL CULTURE;
FEMALE;
FOLLOW UP;
GENE THERAPY;
GENE TRANSFER;
GENE VECTOR;
HUMAN;
IN VITRO STUDY;
MALE;
METHODOLOGY;
MORTALITY;
PANCREAS TUMOR;
PATHOLOGY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
REVIEW;
RISK ASSESSMENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADENOVIRIDAE;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
FEMALE;
FOLLOW-UP STUDIES;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
GENETIC VECTORS;
HUMANS;
MALE;
NEOPLASM STAGING;
PANCREATIC NEOPLASMS;
RISK ASSESSMENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR CELLS, CULTURED;
|
EID: 7044264623
PISSN: 01497944
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cursur.2003.10.002 Document Type: Note |
Times cited : (3)
|
References (41)
|